Navigation Links
WallSt.net Announces Upcoming Interview With CEO of ReBuilder Medical Technologies
Date:12/17/2007

NEW YORK, Dec. 17 /PRNewswire/ -- David B. Phillips, CEO of ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) (http://www.rebuildermedical.com) will be featured in an exclusive interview with http://www.wallst.net scheduled for December 18th. The interview will be posted on http://www.wallst.net by 8 p.m. EST on December 18th.

The interview will cover topics including ReBuilder Medical Technologies, Inc.'s market potential, growth initiatives, competitive edge, recent news, and milestones for which investors should watch.

To hear the interview in its entirety, visit http://www.wallst.net and click on "Interviews." The interview can be accessed by locating the company's ticker symbol (RBRM) under the appropriate exchange at the top of the "Interviews" section or by entering the company's ticker symbol in the Search Archive window.

About ReBuilder Medical Technologies:

RBRM is a manufacturer of medical devices and innovative technologies founded by world-renowned medical device inventor David B. Phillips, Ph.D. The company's flagship product is its FDA registered ReBuilder System(R), used for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) that depend on prescription drugs with powerful side effects, the ReBuilder System(R) is a portable, battery-powered medical product that provides a unique, non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.

ReBuilder Medical Technologies, Inc. also manufactures the Phillips Molluscum Treatment System(TM) for treating the skin disease Molluscum Contagiosum which primarily affects children. This system uses its proprietary form of micronized amorphous silver ion
'/>"/>

SOURCE Financial Filings Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of Osteologix
2. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
3. WallSt.net Announces Upcoming Interview with CEO of BioSante Pharmaceuticals
4. WallSt.net Announces Upcoming Interview With CEO of Biomoda
5. Synvista Therapeutics to be Featured on Wallst.net
6. WallSt.net Announces Upcoming Interview With CEO Of Immunosyn Corporation
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 In support of Swiss contributions ... General of Switzerland in New York is pleased to ... Tûranor PlanetSolar , to Manhattan. PlanetSolar is in ... 2013 tour with scientists on board from the University ... runs exclusively on energy from the sun and eliminates ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 DuPont welcomes ... the 11th annual DuPont National AgriScience Teachers Ambassador Academy ... in Chestertown, Md. , The NATAA ... DuPont and is a special project of the ... of Agricultural Educators (NAAE) . The highly recommended ...
(Date:6/18/2013)... June 18, 2013 ... research firm, announces the initiation of full ... biopharmaceutical company developing and marketing products for ...      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... examining the investment merits of BioAlliance Pharma, ...
(Date:6/18/2013)... Toronto, Canada (PRWEB) June 18, 2013 ... FDA oversight of pharmaceutical advertising and promotion, and ... , Viewers will learn how to apply these ... enforcement examples:, ,     The fundamentals on ... advertising and promotional labeling ,     Assessing traditional ...
Breaking Biology Technology:Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4DuPont Sponsors National AgriScience Ambassador Academy 2DuPont Sponsors National AgriScience Ambassador Academy 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2
... therapy with Pfizer,s recently ... MALIBU, Calif., Nov. 15 Pathway Diagnostics announces,that ... U.S. Patent,number 7,294,458 (the ,458 patent) entitled "Analysis of ... Pathway Diagnostics,has licensed the ,458 patent (with rights to ...
... WYE ),today announced that its Board of Directors ... effective immediately. Mr. Davidson will,continue in his role as ... and divisional financial positions since joining the Company,in 1984. ... Chief,Financial Officer, Wyeth Consumer Healthcare and Deputy Treasurer, Wyeth. ...
... Aida,Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA) today announced that ... September 30, 2007. Net,revenues totaled $7,373,770 for the quarter ... in 2006. Gross profit decreased by 2.66% due to ... from Aida,s,transfusion and injection forms of etimicin sulfate increased ...
Cached Biology Technology:Pathway Diagnostics Announces Patent Issuance for the Diagnostic Measurement of HIV Tropism for the Initiation or Modification of HIV Therapy 2Aida Files 10Q 2Aida Files 10Q 3Aida Files 10Q 4
(Date:6/18/2013)... Obar, Ph.D., Department of Immunology and Infectious Diseases, Montana ... Young Investigator Award for his research on factors affecting ... , Obar earned his B.A. in Microbiology from ... complete his Ph.D. in Microbiology and Immunology from Dartmouth ... research in Edward Usherwood,s laboratory at the Geisel School ...
(Date:6/18/2013)... A team of internationally recognized feline experts including veterinarians ... the University of Lincoln, U.K. and Dr Ilona Rodan, ... by the International Society of Feline Medicine (ISFM) and ... guidelines for veterinarians, owners and those working with cats ... domestic cat. The new guidelines appear in the ...
(Date:6/17/2013)... LA JOLLA, CA June 17, 2013 An ... Institute (TSRI), the Howard Hughes Medical Institute and Albert ... a highly promising new anti-tuberculosis compound that attacks the ... findings represent an effort to help solve one of ... of TB and its dangerous drug-resistant strains," said Peter ...
Breaking Biology News(10 mins):The American Society for Microbiology honors Joshua Obar 2Feline behavior experts release guidelines to improve the welfare of cats 2New compound excels at killing persistent and drug-resistant tuberculosis 2New compound excels at killing persistent and drug-resistant tuberculosis 3New compound excels at killing persistent and drug-resistant tuberculosis 4
... more serious threat to marine life than previously thought. ... (19 July) in the British Ecological Society,s Journal ... of turtles from across the Pacific are being captured ... fisheries in Peru, the study suggests that thousands of ...
... Those solar panels on top of your roof aren,t ... your workplace, too, according to a team of researchers led ... UC San Diego Jacobs School of Engineering. , In ... Solar Energy , Kleissl and his team published what they ...
... 2011) Researchers from the John Theurer Cancer Center ... cancer-related studies during the recently concluded American Society of ... 3 7, 2011 in Chicago. The studies examined ... outcomes, and patient quality of life issues. ...
Cached Biology News:Study shows small-scale fisheries' impact on marine life 2Solar Panels Keep Buildings Cool 2Solar Panels Keep Buildings Cool 3John Theurer Cancer Center researchers shared 14 leading edge studies at recent ASCO meeting 2John Theurer Cancer Center researchers shared 14 leading edge studies at recent ASCO meeting 3John Theurer Cancer Center researchers shared 14 leading edge studies at recent ASCO meeting 4John Theurer Cancer Center researchers shared 14 leading edge studies at recent ASCO meeting 5John Theurer Cancer Center researchers shared 14 leading edge studies at recent ASCO meeting 6
... Immunogen KLH-conjugated, synthetic ... 47-66 (PAEV-GPGAVGERTPRKKEPP) of human BRAF-HDAC ... (BHC110/LSD1). Quality Assurance ... Stability 2 years ...
Request Info...
...
...
Biology Products: